Hana Biosciences (NASDAQ:HNAB), a biopharmaceutical company focused on advancing cancer care, will announce its 2006 second quarter results on Monday, August 14th, prior to the open of the financial markets.
Hana Biosciences (NASDAQ:HNAB), a biopharmaceutical company focused on advancing cancer care, will announce its 2006 second quarter results on Monday, August 14th, prior to the open of the financial markets.
